Hong Kong Pharma Digital Technology Co. Ltd. | Micro-cap | Healthcare
$1.34
8.94%
| Hong Kong Pharma Stock Comparison:
Hong Kong Pharma vs Walgreens BootsHong Kong Pharma vs Wellgistics HealthHong Kong Pharma vs PetMed ExpressHong Kong Pharma vs Scienture HoldingsHong Kong Pharma vs SunLink HealthHong Kong Pharma vs S&P 500 | Market
TL;DR Income Statement Balance Sheet Cash Flow Key Ratios Peer Comparison

TL;DR: Financial Overview - Revenue, Profits & Key Metrics

Income Metrics

Balance Sheet Metrics

Total Assets 9.4M
Total Liabilities 4.4M
Shareholders Equity 5.0M
Debt to Equity 0.89

Cash Flow Metrics

Revenue & Profitability Trend

Hong Kong Pharma Income Statement From 2023 to 2025

Metric202520242023
Revenue i20.3M16.7M12.6M
Cost of Goods Sold i17.9M13.1M9.8M
Gross Profit i2.4M3.6M2.7M
Gross Margin % i11.9%21.3%21.8%
Operating Expenses
Research & Development i---
Selling, General & Administrative i2.2M1.9M1.8M
Other Operating Expenses i-1.5K-4.0K-96.2K
Total Operating Expenses i2.2M1.9M1.7M
Operating Income i200.8K1.7M1.1M
Operating Margin % i1.0%10.0%8.6%
Non-Operating Items
Interest Income i1.7K474219
Interest Expense i97.7K82.8K23.2K
Other Non-Operating Income-68.7K-65.0K-33.3K
Pre-tax Income i36.1K1.5M1.0M
Income Tax i63.2K196.3K22.6K
Effective Tax Rate % i174.9%12.9%2.2%
Net Income i-27.1K1.3M998.2K
Net Margin % i-0.1%8.0%7.9%
Key Metrics
EBITDA i1.3M2.6M1.8M
EPS (Basic) i-$0.12$0.09
EPS (Diluted) i-$0.12$0.09
Basic Shares Outstanding i-1100000011000000
Diluted Shares Outstanding i-1100000011000000

Income Statement Trend

Hong Kong Pharma Balance Sheet From 2023 to 2025

Metric202520242023
Assets
Current Assets
Cash & Equivalents i748.7K619.6K524.6K
Short-term Investments i2.3M0-
Accounts Receivable i4.7M3.7M1.6M
Inventory i560.0K933.3K190.9K
Other Current Assets---
Total Current Assets i8.7M7.8M2.7M
Non-Current Assets
Property, Plant & Equipment i650.4K855.1K599.7K
Goodwill i96.4K31.8K4.0K
Intangible Assets i96.4K31.8K4.0K
Long-term Investments---
Other Non-Current Assets---
Total Non-Current Assets i690.2K865.5K658.3K
Total Assets i9.4M8.7M3.4M
Liabilities
Current Liabilities
Accounts Payable i1.7M1.3M1.4M
Short-term Debt i864.7K849.7K419.6K
Current Portion of Long-term Debt---
Other Current Liabilities---
Total Current Liabilities i2.9M3.2M2.6M
Non-Current Liabilities
Long-term Debt i1.5M1.2M271.5K
Deferred Tax Liabilities i---
Other Non-Current Liabilities---
Total Non-Current Liabilities i1.5M1.2M271.5K
Total Liabilities i4.4M4.4M2.8M
Equity
Common Stock i11.0K10.0K6.8K
Retained Earnings i1.5M1.5M201.4K
Treasury Stock i---
Other Equity---
Total Shareholders Equity i5.0M4.3M585.2K
Key Metrics
Total Debt i2.4M2.1M691.1K
Working Capital i5.8M4.6M198.4K

Balance Sheet Composition

Hong Kong Pharma Cash Flow Statement From 2023 to 2025

Metric202520242023
Operating Activities
Net Income i-27.1K1.3M998.2K
Depreciation & Amortization i1.1M925.6K714.6K
Stock-Based Compensation i---
Working Capital Changes i-405.4K-2.8M-8.3K
Operating Cash Flow i640.9K-589.9K1.7M
Investing Activities
Capital Expenditures i-69.9K-19.5K-114.6K
Acquisitions i---
Investment Purchases i-2.3M00
Investment Sales i---
Investing Cash Flow i-2.4M-5.5K-129.0K
Financing Activities
Share Repurchases i---
Dividends Paid i---
Debt Issuance i1.6M2.1M189.2K
Debt Repayment i-2.5M-1.8M-1.3M
Financing Cash Flow i2.0M537.3K-1.2M
Free Cash Flow i414.2K-482.3K1.6M
Net Change in Cash i266.2K-58.1K419.8K

Cash Flow Trend

Hong Kong Pharma Key Financial Ratios

Valuation Ratios

P/E Ratio (TTM) 6.26
Price to Book 2.71
Price to Sales 0.67

Profitability Ratios

Profit Margin -0.13%
Operating Margin -9.05%
Return on Equity -0.59%
Return on Assets 1.32%

Financial Health

Current Ratio 2.99
Debt to Equity 47.60

Per Share Data

EPS (TTM) $0.00
Book Value per Share $0.45
Revenue per Share $1.99

Peer Financial Comparison

CompanyMarket CapP/E RatioP/B RatioROEProfit MarginDebt/Equity
hkpd14.3M6.262.71-0.59%-0.13%47.60
Walgreens Boots 10.4B27.101.44-69.58%-4.07%409.88
Wellgistics Health 65.6M-4.6848.46-101.81%-123.31%2,722.18
PetMed Express 58.5M262.000.560.36%0.15%1.15
Scienture Holdings 18.3M1.700.18-54.26%4.39%5.30
SunLink Health 7.0M-5.070.59-22.34%5.55%4.98

Financial data is updated regularly. All figures are in the company's reporting currency.